Gain a comprehensive picture of your brain health by measuring five key biomarkers linked to memory, cognitive resilience and future dementia risk.
Patients were seen as new referrals in advance of assessing for LT or following a negative outcome in the listing meeting, requiring further input from the clinic before representation, if appropriate
Ideal when you want extra support during busy high exposure weeks
Hassenbusch, MD, PhD PRS Leadership & Institutional Service Award, The University of Texas MD Anderson Cancer Center, 2022 - Present Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2020 - Present Vice-Chair, Institutional Review Board, The University of Texas MD Anderson Cancer Center, 2019 - Present Member, CME Advisory Committee, The University of Texas MD Anderson Cancer Center, 2018 - 2019 Member- Division of Cancer Medicine, PRS Clinical Revenue Cycle Committee, The University of Texas MD Anderson Cancer Center, 2017 - Present Senator, Faculty Senate, The University of Texas MD Anderson Cancer Center, 2015 - 2017 Member, Institutional Review Board 5, The University of Texas MD Anderson Cancer Center, 2013 - Present Member, Institutional Research Grant Study Section Review Committee for Clinical Translational and Population-based Research Projects, The University of Texas MD Anderson Cancer Center, 2012 - Present Member, Clinical Research Committee 1, The University of Texas MD Anderson Cancer Center, 2012 - 2014 Associate Member, Institutional Review Board 5, The University of Texas MD Anderson Cancer Center, 2012 - 2013 Committee Chair, Institutional Research Grant Study Section Review Committee for Clinical Translational and Population-based Research Projects, The University of Texas MD Anderson Cancer Center, 2011 - 2012 Member, Institutional Review Board 5, The University of Texas MD Anderson Cancer Center, 2011 - 2012 Vice Chairman, Institutional Research Grant Study Section Review Committee for Clinical Translational and Population-based Research Projects, The University of Texas MD Anderson Cancer Center, 2010 - 2011 Member, Institutional Research Grant Study Section Review Committee for Clinical Translational and Population-based Research Projects, The University of Texas MD Anderson Cancer Center, 2009 - 2010 Member, Clinical Research Committee 4, The University of Texas MD Anderson Cancer Center, 2007 - 2010 Member, Sepsis Order Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007 Member, Anemia Guidelines Committee, The University of Texas MD Anderson Cancer Center, 2006 - 2007 Editorial Activities Editorial Board Member, Leukemia & Lymphoma, 2021 - Present Editorial Board Member, American Journal of Hematology, 2019 - 2022 Editorial Board Member, Acta Haematologica, 2017 Associate Editor, Frontiers in Hematology Oncology, 2011 Editorial Board Member, Personalized Medicine in Oncology, 2011 Honors & Awards Professional Memberships Society of Hematologic Oncology 2013 - Present Indo-American Cancer Association 2011 - Present Harris County Medical Society 2007 - Present Texas Medical Society 2007 - Present American Association for Cancer Research 2006 - Present American Society of Hematology 2001 - Present American Society of Clinical Oncology 2001 - Present Selected Presentations & Talks Local Presentations 2025
Toll-like 4 receptor inhibitor tak-242 decreases neuroinflammation in rat brain frontal cortex after stress
Are there any skin types that should avoid these acids
